NCT03705572

Brief Summary

Six week RCT intervention on the effects of phospholipid containing milk drink vs. placebo milk drink on cognitive performance in 6-8 year old school children.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
165

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started May 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2016

Completed
2.3 years until next milestone

First Posted

Study publicly available on registry

October 15, 2018

Completed
Last Updated

October 15, 2018

Status Verified

October 1, 2018

Enrollment Period

11 months

First QC Date

July 7, 2016

Last Update Submit

October 12, 2018

Conditions

Keywords

MilkLacprodan PL20GlycerophospholipidsCognition

Outcome Measures

Primary Outcomes (1)

  • Rivermead Behavioural Memory Test for Children (RBMT-C) change from baseline

    Test of immediate and delayed verbal memory recall.

    Week 0, week 3 & week 6

Secondary Outcomes (5)

  • Motor Screening Task (CANTAB suite) change from baseline

    Week 0, week 3 & week 6

  • Spatial Recognition Memory (CANTAB suite) change from baseline

    Week 0, week 3 & week 6

  • Spatial Span (CANTAB suite) change from baseline

    Week 0, week 3 & week 6

  • Reaction time (CANTAB suite) change from baseline

    Week 0, week 3 & week 6

  • Subjective mood questionnaire change from baseline

    Week 0, week 3 & week 6

Study Arms (2)

Dietary Supplement: Phospholipid drink.

ACTIVE COMPARATOR

Participant in an intervention parallel group consumed a drink with added phospholipids (Lacprodan PL20).

Dietary Supplement: Lacprodan PL20

Dietary Supplement: Placebo milk drink.

PLACEBO COMPARATOR

Participant in an intervention parallel group consumed a drink without added phospholipids.

Other: Placebo

Interventions

Lacprodan PL20DIETARY_SUPPLEMENT

Milk protein concentrate that is high in phospholipid content (min 16%).

Dietary Supplement: Phospholipid drink.
PlaceboOTHER

Placebo milk drink.

Dietary Supplement: Placebo milk drink.

Eligibility Criteria

Age6 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Male or female, aged 6-8 years.
  • Willingness to consume milk drinks during the study determined by a score of \>5 on a taste testing Likert scale for at least one flavour of the milk drinks.
  • Ability to follow verbal and simple written instructions in English.
  • Normal vision, with appropriate corrective lenses if required.
  • Ability to understand cognitive testing instructions and responding requirements.

You may not qualify if:

  • Poor general health.
  • Colour blindness.
  • Behavioural difficulties or attention disorders (e.g. Attention Deficit Hyperactivity Disorder).
  • Learning disabilities that interfere with the ability to understand written or verbal communications.
  • Inability to understand the objective of the cognitive tests, or carry out the tests.
  • Any food allergies or intolerances (e.g. lactose intolerance).
  • Acute illness, or feelings of unwell, within the week prior to testing.
  • Current administration of any psychotropic medication or supplementation in the month prior to testing, or during testing.
  • Hearing impairment that precludes the ability to follow verbal instructions.
  • Children already receiving milk at school unless parents are willing to substitute current milk with the study milk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

lacprodan PL-20

Study Officials

  • Louise Dye, PhD

    Professor of Nutrition & Behaviour; Lead for Strategic Development.

    PRINCIPAL INVESTIGATOR
  • Clare Lawton, PhD

    Associate Professor of Nutrition & Behaviour.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 7, 2016

First Posted

October 15, 2018

Study Start

May 1, 2014

Primary Completion

April 1, 2015

Study Completion

April 1, 2015

Last Updated

October 15, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share